These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16568086)

  • 1. MEKK1 controls matrix degradation and tumor cell dissemination during metastasis of polyoma middle-T driven mammary cancer.
    Cuevas BD; Winter-Vann AM; Johnson NL; Johnson GL
    Oncogene; 2006 Aug; 25(36):4998-5010. PubMed ID: 16568086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice.
    Bugge TH; Lund LR; Kombrinck KK; Nielsen BS; Holmbäck K; Drew AF; Flick MJ; Witte DP; Danø K; Degen JL
    Oncogene; 1998 Jun; 16(24):3097-104. PubMed ID: 9671388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEKK1 regulates the AP-1 dimer repertoire via control of JunB transcription and Fra-2 protein stability.
    Cuevas BD; Uhlik MT; Garrington TP; Johnson GL
    Oncogene; 2005 Jan; 24(5):801-9. PubMed ID: 15558021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer.
    Vasiljeva O; Papazoglou A; Krüger A; Brodoefel H; Korovin M; Deussing J; Augustin N; Nielsen BS; Almholt K; Bogyo M; Peters C; Reinheckel T
    Cancer Res; 2006 May; 66(10):5242-50. PubMed ID: 16707449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease.
    Szabova L; Chrysovergis K; Yamada SS; Holmbeck K
    Oncogene; 2008 May; 27(23):3274-81. PubMed ID: 18071307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
    Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
    J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation of MEK kinase 1 suppresses intimal hyperplasia by impairing smooth muscle cell migration and urokinase plasminogen activator expression in a mouse blood-flow cessation model.
    Li Y; Minamino T; Tsukamoto O; Yujiri T; Shintani Y; Okada K; Nagamachi Y; Fujita M; Hirata A; Sanada S; Asanuma H; Takashima S; Hori M; Johnson GL; Kitakaze M
    Circulation; 2005 Apr; 111(13):1672-8. PubMed ID: 15795331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model.
    Mitra SK; Lim ST; Chi A; Schlaepfer DD
    Oncogene; 2006 Jul; 25(32):4429-40. PubMed ID: 16547501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice.
    Zhang H; Kuang SQ; Liao L; Zhou S; Xu J
    Cancer Res; 2004 Oct; 64(19):7169-77. PubMed ID: 15466215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
    Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D
    Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation.
    Hulit J; Suyama K; Chung S; Keren R; Agiostratidou G; Shan W; Dong X; Williams TM; Lisanti MP; Knudsen K; Hazan RB
    Cancer Res; 2007 Apr; 67(7):3106-16. PubMed ID: 17409417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice.
    Sevenich L; Werner F; Gajda M; Schurigt U; Sieber C; Müller S; Follo M; Peters C; Reinheckel T
    Oncogene; 2011 Jan; 30(1):54-64. PubMed ID: 20818432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined treatment with verapamil, a calcium channel blocker, and B428, a synthetic uPA inhibitor, impairs the metastatic ability of a murine mammary carcinoma.
    Todaro LB; Ladeda V; Bal de Kier Joffé E; Farías EF
    Oncol Rep; 2003; 10(3):725-32. PubMed ID: 12684650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
    Bierie B; Stover DG; Abel TW; Chytil A; Gorska AE; Aakre M; Forrester E; Yang L; Wagner KU; Moses HL
    Cancer Res; 2008 Mar; 68(6):1809-19. PubMed ID: 18339861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sam68 haploinsufficiency delays onset of mammary tumorigenesis and metastasis.
    Richard S; Vogel G; Huot ME; Guo T; Muller WJ; Lukong KE
    Oncogene; 2008 Jan; 27(4):548-56. PubMed ID: 17621265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.
    Brantley-Sieders DM; Fang WB; Hwang Y; Hicks D; Chen J
    Cancer Res; 2006 Nov; 66(21):10315-24. PubMed ID: 17079451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
    Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
    Zuo Y; Ulu A; Chang JT; Frost JA
    Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of polyamine depletion by alpha-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells.
    Jun JY; Griffith JW; Bruggeman R; Washington S; Demers LM; Verderame MF; Manni A
    Breast Cancer Res Treat; 2008 Jan; 107(1):33-40. PubMed ID: 17333337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
    Yoo YA; Kang MH; Kim JS; Oh SC
    Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.